Nath Bio-Genes (India) Limited (NATHBIOGEN) — Cash Flow Reinvestment Rate
Nath Bio-Genes (India) Limited (NATHBIOGEN) has a Cash Flow Reinvestment Rate of 0.45x as of March 2025, reinvesting Rs79.20 Million (capex Rs79.20 Million ) from operating cash flow of Rs175.81 Million. Check NATHBIOGEN cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Nath Bio-Genes (India) Limited Cash Flow Reinvestment Rate (2013–2025)
Historical reinvestment intensity for Nath Bio-Genes (India) Limited across 10 annual periods. Explore NATHBIOGEN long-term investments to assets to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Nath Bio-Genes (India) Limited (2013–2025)
Year-by-year capital reinvestment analysis for Nath Bio-Genes (India) Limited. For live market cap and broader valuation context, see Nath Bio-Genes (India) Limited stock valuation.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.68x | Rs118.82 Million | Rs175.81 Million | Rs79.20 Million | ▲ +16.1% |
| 2024 | 0.58x | Rs357.97 Million | Rs614.80 Million | Rs83.93 Million | ▲ +311.2% |
| 2023 | 0.14x | Rs54.33 Million | Rs383.67 Million | Rs25.49 Million | ▼ -88.5% |
| 2022 | 1.23x | Rs210.32 Million | Rs170.46 Million | Rs210.17 Million | ▼ -88.2% |
| 2021 | 10.47x | Rs116.49 Million | Rs11.13 Million | Rs115.98 Million | ▲ +512.0% |
| 2020 | 1.71x | Rs162.04 Million | Rs94.74 Million | Rs162.03 Million | ▲ +38.6% |
| 2017 | 1.23x | Rs41.26 Million | Rs33.43 Million | Rs41.26 Million | ▲ +1080.3% |
| 2015 | 0.10x | Rs7.06 Million | Rs67.55 Million | Rs7.06 Million | ▼ -45.7% |
| 2014 | 0.19x | Rs28.95 Million | Rs150.28 Million | Rs28.95 Million | ▼ -87.2% |
| 2013 | 1.50x | Rs213.54 Million | Rs142.11 Million | Rs213.54 Million | — |